RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/sciadv.abn1382
PubMed Identifier: 35857500
Publication URI: http://europepmc.org/abstract/MED/35857500
Type: Journal Article/Review
Volume: 8
Parent Publication: Science advances
Issue: 28
ISSN: 2375-2548